Concepedia

Publication | Open Access

Early Experiences Implementing Pre-exposure Prophylaxis (PrEP) for HIV Prevention in San Francisco

DOIFull Paper Access

257

Citations

34

References

2014

Year

Albert Liu, Stephanie E. Cohen, Stephen Follansbee, Deborah Cohan, Shannon Weber, Darpun Sachdev, Susan Buchbinder
PLoS Medicine

Abstract

N Pre-exposure prophylaxis (PrEP) has been demonstrated to be safe and efficacious in clinical trials and emtricitabine/tenofovir was approved by the United States Food and Drug Administration for use as PrEP in 2012.

References

YearCitations

Page 1